Tag: bisphosphonates
Articles
News
- A story of long-term stage IV HER2+ breast cancer survival
- Adding the bisphosphonate zoledronic acid to chemotherapy does not improve outcome markers
- Bisphosphonate treatment does not appear to increase survival in early stage breast cancer
- Bisphosphonate Zometa might increase survival in certain premenopausal breast cancer cases
- Bisphosphonates for treating osteoporosis may significantly reduce risk of breast cancer
- Bisphosphonates may reduce survival in women with nonmetastatic breast cancer
- DCIS incidence has increased in recent years
- Only modest increase in jaw necrosis in Avastin combined with bisphosphonate treatment
- Preliminary study finds Boniva can eradicate dormant breast cancer cells in bone marrow
- The bisphosphonate zoledronic acid might reduce breast cancer recurrence in postmenopausal women
- Vitamin D supplementation counteracts side effect of treatment for bone metastases
Studies
- A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases
- Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?
- ANZAC: A Randomised Neoadjuvant Biomarker Study Investigating the Anti-Tumour Activity of the Addition of Zoledronic Acid to Chemotherapy in Breast Cancer
- Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer
- Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer
- Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer
- Bisphosphonates may significantly reduce risk of breast cancer
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- Clodronate Appeared Safe, Modestly Affected Breast Cancer Disease Events
- Does Adjuvant Bisphosphonate in Early Breast Cancer Modify the Natural Course of the Disease? A Meta-Analysis of Randomized Controlled Trials
- Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial
- Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study
- Final 5-year results of Z-FAST trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole
- Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients
- Oral Bisphosphonate Did Not Improve Prognosis for Patients With Breast Cancer
- Outcome of patients with nonmetastatic breast cancer receiving nitrogen-containing bisphosphonates: A comparative analysis from the Metropolitan Detroit Cancer Surveillance System (MDCSS)
- Preventive Effects of Zoledronic Acid on Bone Metastasis in Mice Injected with Human Breast Cancer Cells
- Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases
- The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trials
- The Protective Effect of Zoledronic Acid on Bone Loss in Postmenopausal Women with Early Breast Cancer Treated with Sequential Tamoxifen and Letrozole: A Prospective, Randomized, Phase II Trial
- Zoledronic Acid Shows Long-Term Benefit in Survivorship for Premenopausal ER-Positive Breast Cancer